1110 — Kingworld Medicines Income Statement
0.000.00%
Last trade - 00:00
- HK$336.15m
- HK$596.43m
- CNY1.08bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 978 | 745 | 847 | 958 | 1,079 |
Cost of Revenue | |||||
Gross Profit | 267 | 280 | 264 | 278 | 281 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 901 | 672 | 775 | 885 | 982 |
Operating Profit | 76.7 | 73.6 | 72.2 | 72.2 | 96.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 69.8 | 70.9 | 69.4 | 67.6 | 93.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 50.3 | 50.9 | 51.2 | 43.5 | 61.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 43.4 | 11.7 | 30.3 | 22.7 | 38.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 43.4 | 11.7 | 30.3 | 22.7 | 38.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.07 | 0.018 | 0.052 | 0.037 | 0.064 |
Dividends per Share |